Market Overview: The Global End-Stage Renal Disease Market is expected to reach a value of USD 119.4 billion in 2023, and it is further anticipated to reach a market value of USD 398.7 billion by 2032 at a CAGR of 14.2%. The End-Stage Renal Disease (ESRD) Market encompasses treatments, therapies, and medical devices aimed at managing the advanced stage of chronic kidney disease where kidney...